CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Significant Growth in Short Interest

CellaVision AB (publ) (OTCMKTS:CLVSF) was the recipient of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 6,115 shares, an increase of 354.6% from the May 31st total of 1,345 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

CellaVision AB (publ) Stock Performance

Shares of CellaVision AB (publ) stock opened at $14.00 on Friday. CellaVision AB has a 52 week low of $13.49 and a 52 week high of $17.30. The company’s 50-day moving average price is $13.77 and its two-hundred day moving average price is $15.52.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.